SMT指导下的护理支持干预模式对乳腺癌术后化疗患者生存质量的影响

打开文本图片集

Effectof Nursing Support Intervention Model Guided by SMTon QualityofLife inPostoperative Chemotherapy Patients with Breast Cancer/CHEN Shanyu，LIHong.//Medical Innovationof China，2025， 22（30）： 067-071

[Abstract]Objective： To analyze the influence of the nursing support intervention model guided by symptom management theory （SMT）on postoperative chemotherapy patients with breast cancer.Method： A total of 120 postoperative chemotherapy patients with breast cancer admitted to the Breast Surgery Department of Guizhou Medical University Afiliated Hospital from January 2O22 to June 2O24 were selected.These patients were randomly divided into two groups using a random number table method， with 6O cases in each group.The control group received standard nursing，while the observation group received the nursing support intervention model guided by SMTon the basis of the control group.The scores of Chinese versions of the memorial symptom assessment scale （MSAS），demoralizationscale II （DC-II），and functional assssmentofcancer therapy-breast （FACT-B）between the two groups were compared.Result： After chemotherapy，the MSAS score of the observation group was lower than that of the control group （ P <0.05）.After chemotherapy，the DC-II score of the observation group was lower than that of the control group （ P <0.05）.After chemotherapy，the scores of physical condition，social/family，emotional condition and functional condition in FACT-Bof the observation group were higherthanthose of thecontrol group （ P <0.05）.Conclusion： The nursing support intervention model guided by SMT can reducethe degree of symptom distress and improve the quality of life of breast cancer chemotherapy patients.

[Keywords] Symptom management theory Nursing support intervention Breast cancer Chemotherapy

First-author's address：Breast Surgery Department， Guizhou Medical University Afiliated Hospital， Guiyang550000，China

doi：10.3969/j.issn.1674-4985.2025.30.017

乳腺癌是危害女性健康的主要恶性肿瘤，据2020年全球癌症报告显示，乳腺癌发病率（ 24.2% ）及死亡率（ 15.0% ）均居女性所有恶性肿瘤发病率和死亡率的第一位[]。（剩余6475字）